Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stress and Opioid Misuse Risk
NCT05142267Phase 4Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- Mar 2022
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of oxycodone and naloxone in low back pain (LBP), sponsored by Vanderbilt University Medical Center. Primary endpoints: McGill Pain Questionnaire-2 at 15 days, DELTA Drug Liking subscale at 1 day and 1 more. Started Mar 2022; status: completed.
02
Drugs
oxycodonenaloxone
03
Conditions
low back pain (LBP)
Beyond the preview
Go deeper on NCT05142267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05142267.